Contineum Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Contineum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Contineum Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Contineum Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 964k | 11.75 |
| 2025-06-30 | $3.0M | 744k | 3.97 |
| 2025-03-31 | $5.6M | 803k | 6.98 |
| 2024-12-31 | $12M | 809k | 14.65 |
| 2024-09-30 | $8.8M | 461k | 19.14 |
| 2024-06-30 | $8.3M | 472k | 17.61 |